Karyopharm Therapeutics Current Ratio 2012-2020 | KPTI

Karyopharm Therapeutics current ratio from 2012 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Karyopharm Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-09-30 $0.29B $0.05B 5.42
2020-06-30 $0.32B $0.05B 6.29
2020-03-31 $0.37B $0.05B 7.46
2019-12-31 $0.28B $0.05B 6.01
2019-09-30 $0.28B $0.04B 7.17
2019-06-30 $0.22B $0.03B 6.93
2019-03-31 $0.27B $0.04B 6.19
2018-12-31 $0.34B $0.05B 7.13
2018-09-30 $0.21B $0.04B 5.09
2018-06-30 $0.25B $0.04B 6.69
2018-03-31 $0.13B $0.05B 2.85
2017-12-31 $0.15B $0.05B 3.00
2017-09-30 $0.12B $0.02B 5.75
2017-06-30 $0.15B $0.02B 8.32
2017-03-31 $0.11B $0.02B 7.25
2016-12-31 $0.13B $0.02B 7.99
2016-09-30 $0.13B $0.02B 8.71
2016-06-30 $0.12B $0.02B 8.00
2016-03-31 $0.14B $0.01B 10.45
2015-12-31 $0.18B $0.02B 11.74
2015-09-30 $0.20B $0.01B 13.74
2015-06-30 $0.23B $0.01B 15.98
2015-03-31 $0.25B $0.02B 16.96
2014-12-31 $0.21B $0.01B 16.89
2014-09-30 $0.23B $0.01B 37.11
2014-06-30 $0.14B $0.01B 23.96
2014-03-31 $0.15B $0.01B 29.43
2013-12-31 $0.16B $0.00B 47.98
2013-09-30 $0.05B $0.00B 13.41
2013-06-30 $0.02B $0.00B 7.16
2013-03-31 $0.00B 0.00
2012-12-31 $0.00B 0.00
2012-09-30 $0.00B 0.00
2012-06-30 $0.00B 0.00
2011-12-31 $0.01B $0.00B 3.25
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.087B $0.108B
Karyopharm Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on the discovery and development of drugs for the treatment of cancer and other major diseases. It serves the healthcare industry throughout the United States. Karyopharm Therapeutics, Inc. is based in United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $74.354B 40.64
Takeda Pharmaceutical (TAK) Japan $52.809B 9.68
Astellas Pharma (ALPMY) Japan $30.757B 18.99
Eisai (ESALY) Japan $21.059B 23.36
Catalent (CTLT) United States $19.108B 50.56
Grifols, S.A (GRFS) Spain $11.255B 12.89
Neurocrine Biosciences (NBIX) United States $10.034B 23.27
Jazz Pharmaceuticals (JAZZ) Ireland $9.617B 16.06
Arrowhead Pharmaceuticals (ARWR) United States $8.532B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.900B 0.00
Ionis Pharmaceuticals (IONS) United States $7.523B 0.00
United Therapeutics (UTHR) United States $7.519B 14.60
IPSEN SA ADR (IPSEY) France $7.175B 0.00
Evotec AG (EVTCY) Germany $6.425B 433.89
Orion OYJ (ORINY) Finland $5.794B 20.11
Sage Therapeutics (SAGE) United States $4.872B 0.00
ChemoCentryx (CCXI) United States $4.559B 0.00
FibroGen (FGEN) United States $4.538B 0.00
Tilray (TLRY) Canada $4.208B 0.00
Nektar Therapeutics (NKTR) United States $4.026B 0.00
Hypermarcas (HYPMY) Brazil $3.940B 15.55
Cronos Group (CRON) Canada $3.887B 0.00
PTC Therapeutics (PTCT) United States $3.766B 0.00
Pacira BioSciences (PCRX) United States $3.234B 55.15
Corcept Therapeutics (CORT) United States $2.999B 30.07
Revolution Medicines (RVMD) United States $2.998B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.750B 17.03
Xencor (XNCR) United States $2.710B 0.00
AlloVir (ALVR) United States $2.617B 0.00
Endo (ENDP) Ireland $2.144B 3.24
Sundial Growers (SNDL) Canada $2.139B 0.00
USANA Health Sciences (USNA) United States $2.029B 16.46
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.856B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.849B 0.00
ImmunoGen (IMGN) United States $1.710B 0.00
Translate Bio (TBIO) United States $1.654B 0.00
Heron Therapeutics (HRTX) United States $1.650B 0.00
Organogenesis Holdings (ORGO) United States $1.563B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.466B 10.19
Ironwood Pharmaceuticals (IRWD) United States $1.455B 11.44
Ocular Therapeutix (OCUL) United States $1.374B 0.00
Indivior (INVVY) United States $1.312B 0.00
Zogenix (ZGNX) United States $1.234B 0.00
Trillium Therapeutics (TRIL) Canada $1.179B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.108B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.020B 0.00
Vectura Group (VEGPF) United Kingdom $0.952B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Aclaris Therapeutics (ACRS) United States $0.911B 0.00
Collegium Pharmaceutical (COLL) United States $0.900B 34.25
Radius Health (RDUS) United States $0.886B 0.00
VAXART, INC (VXRT) United States $0.821B 0.00
Esperion Therapeutics (ESPR) United States $0.773B 0.00
Aerie Pharmaceuticals (AERI) United States $0.740B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.700B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.691B 0.00
Chinook Therapeutics (KDNY) United States $0.686B 0.00
KalVista Pharmaceuticals (KALV) United States $0.596B 0.00
Rafael Holdings (RFL) United States $0.591B 0.00
Ardelyx (ARDX) United States $0.584B 0.00
Acutus Medical (AFIB) United States $0.582B 0.00
Summit Therapeutics (SMMT) United States $0.576B 0.00
Altimmune (ALT) United States $0.569B 0.00
Molecular Templates (MTEM) United States $0.551B 0.00
Flexion Therapeutics (FLXN) United States $0.546B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.525B 0.00
AVITA Medical (RCEL) United States $0.504B 0.00
Akebia Therapeutics (AKBA) United States $0.502B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.495B 0.00
Siga Technologies (SIGA) United States $0.494B 13.87
Avadel Pharmaceuticals (AVDL) Ireland $0.493B 0.00
Jounce Therapeutics (JNCE) United States $0.469B 0.00
Harpoon Therapeutics (HARP) United States $0.465B 0.00
TherapeuticsMD (TXMD) United States $0.462B 0.00
DURECT (DRRX) United States $0.460B 0.00
PROFOUND MEDICL (PROF) Canada $0.436B 0.00
MEI Pharma (MEIP) United States $0.416B 0.00
Redhill Biopharma (RDHL) Israel $0.413B 0.00
VYNE Therapeutics (VYNE) United States $0.405B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.404B 10.54
Innate Pharma SA (IPHYF) France $0.350B 0.00
Nature's Sunshine Products (NATR) United States $0.334B 21.53
CASI Pharmaceuticals (CASI) United States $0.309B 0.00
Onconova Therapeutics (ONTX) United States $0.281B 0.00
Alpine Immune Sciences (ALPN) United States $0.272B 0.00
Xeris Pharmaceuticals (XERS) United States $0.265B 0.00
Oncternal Therapeutics (ONCT) United States $0.264B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.257B 0.00
Lannett Co Inc (LCI) United States $0.255B 8.57
Jaguar Animal Health (JAGX) United States $0.251B 0.00
CTI BioPharma (CTIC) United States $0.247B 0.00
Novan (NOVN) United States $0.241B 0.00
IMV INC (IMV) Canada $0.224B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.221B 0.00
Iterum Therapeutics (ITRM) Ireland $0.212B 0.00
Concert Pharmaceuticals (CNCE) United States $0.211B 0.00
Qilian Holding Group (QLI) China $0.210B 0.00
OptiNose (OPTN) United States $0.209B 0.00
IsoRay (ISR) United States $0.206B 0.00
Calithera Biosciences (CALA) United States $0.205B 0.00
Infinity Pharmaceuticals (INFI) United States $0.204B 0.00
Taiwan Liposome (TLC) Taiwan $0.201B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.194B 0.00
Nutriband (NTRB) United States $0.194B 0.00
Heat Biologics (HTBX) United States $0.181B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.176B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.171B 0.00
Aquestive Therapeutics (AQST) United States $0.169B 0.00
KemPharm (KMPH) United States $0.164B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.160B 0.00
Genocea Biosciences (GNCA) United States $0.159B 0.00
Aziyo Biologics (AZYO) United States $0.157B 0.00
Champions Oncology (CSBR) United States $0.153B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.153B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.149B 0.00
MediWound (MDWD) Israel $0.144B 0.00
Otonomy (OTIC) United States $0.143B 0.00
Lipocine (LPCN) United States $0.125B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.118B 0.00
ProPhase Labs (PRPH) United States $0.117B 0.00
Recro Pharma (REPH) United States $0.116B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.109B 0.00
Assertio Holdings (ASRT) United States $0.108B 0.00
Natural Alternatives (NAII) United States $0.106B 28.72
Baudax Bio (BXRX) United States $0.098B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.097B 0.00
ElectroCore (ECOR) United States $0.097B 0.00
AIM ImmunoTech (AIM) United States $0.096B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.087B 0.00
SCYNEXIS (SCYX) United States $0.086B 0.00
India Globalization Capital (IGC) United States $0.082B 0.00
PolarityTE (PTE) United States $0.080B 0.00
AgeX Therapeutics (AGE) United States $0.079B 0.00
Biomerica (BMRA) United States $0.074B 0.00
CV Sciences (CVSI) United States $0.073B 0.00
Inhibikase Therapeutics (IKT) United States $0.071B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.068B 0.00
Sigyn Therapeutics (SIGY) United States $0.065B 0.00
Brickell Biotech (BBI) United States $0.064B 0.00
Plus Therapeutics (PSTV) United States $0.063B 0.00
Addex Therapeutics (ADXN) Switzerland $0.062B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
Regulus Therapeutics (RGLS) United States $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 25.85
NovaBay Pharmaceuticals (NBY) United States $0.047B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.046B 0.00
Neos Therapeutics (NEOS) United States $0.045B 0.00
RXi Pharmaceuticals (PHIO) United States $0.044B 0.00
Mannatech (MTEX) United States $0.037B 5.46
Can-Fite Biopharma (CANF) Israel $0.033B 0.00
China SXT Pharmaceuticals (SXTC) China $0.032B 0.00
Midatech Pharma (MTP) United Kingdom $0.031B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.028B 0.00
JanOne (JAN) United States $0.023B 0.00
Cyanotech (CYAN) United States $0.023B 18.85
Bellicum Pharmaceuticals (BLCM) United States $0.023B 0.00
HANCOCK JAFFE (HJLI) United States $0.019B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Xenetic Biosciences (XBIO) United States $0.017B 0.00
SHINECO INC (TYHT) China $0.014B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00